Small-molecule inhibitors of histone deacetylase for the treatment of cancer and non-cancer diseases: a patent review (2011 – 2013)
出版年份 2014 全文链接
标题
Small-molecule inhibitors of histone deacetylase for the treatment of cancer and non-cancer diseases: a patent review (2011 – 2013)
作者
关键词
-
出版物
EXPERT OPINION ON THERAPEUTIC PATENTS
Volume 24, Issue 4, Pages 401-415
出版商
Informa Healthcare
发表日期
2014-01-08
DOI
10.1517/13543776.2014.877446
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Histone Deacetylase Inhibitors: An Attractive Strategy for Cancer Therapy
- (2013) Jiyang Li et al. CURRENT MEDICINAL CHEMISTRY
- Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma
- (2012) L. Santo et al. BLOOD
- A Phase I Pharmacokinetic and Pharmacodynamic Study of CHR-3996, an Oral Class I Selective Histone Deacetylase Inhibitor in Refractory Solid Tumors
- (2012) U. Banerji et al. CLINICAL CANCER RESEARCH
- HDAC inhibitor-based therapies: Can we interpret the code?
- (2012) Maria New et al. Molecular Oncology
- Developing Histone Deacetylase Inhibitors as Anti-Cancer Therapeutics
- (2011) B. Venugopal et al. CURRENT MEDICINAL CHEMISTRY
- Preclinical validation of AR42, a novel histone deacetylase inhibitor, as treatment for vestibular schwannomas
- (2011) Abraham Jacob et al. LARYNGOSCOPE
- Epigenetic treatment of neurological disease
- (2011) Steven G Gray Epigenomics
- Preclinical anti-myeloma activity of the novel HDAC-inhibitor JNJ-26481585
- (2010) Thorsten Stühmer et al. BRITISH JOURNAL OF HAEMATOLOGY
- research paper: Differential expression of HDAC3, HDAC7 and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia
- (2010) Daniel Antunes Moreno et al. BRITISH JOURNAL OF HAEMATOLOGY
- Anti-inflammatory Agents: Present and Future
- (2010) Charles A. Dinarello CELL
- The clinical development of histone deacetylase inhibitors as targeted anticancer drugs
- (2010) Paul A Marks EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Discovery of 2-(6-{[(6-Fluoroquinolin-2-yl)methyl]amino}bicyclo[3.1.0]hex-3-yl)-N-hydroxypyrimidine-5-carboxamide (CHR-3996), a Class I Selective Orally Active Histone Deacetylase Inhibitor
- (2010) David Moffat et al. JOURNAL OF MEDICINAL CHEMISTRY
- Expression of histone deacetylases in lymphoma: implication for the development of selective inhibitors
- (2009) Annunziata Gloghini et al. BRITISH JOURNAL OF HAEMATOLOGY
- Phase I Study of Vorinostat in Combination with Bortezomib for Relapsed and Refractory Multiple Myeloma
- (2009) A. Badros et al. CLINICAL CANCER RESEARCH
- Targeting of HDAC8 and investigational inhibitors in neuroblastoma
- (2009) Ina Oehme et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Inhibition of HDAC9 Increases T Regulatory Cell Function and Prevents Colitis in Mice
- (2009) Edwin F. de Zoeten et al. GASTROENTEROLOGY
- Expression of Hypoxia-Inducible Factor-1α, Histone Deacetylase 1, and Metastasis-Associated Protein 1 in Pancreatic Carcinoma
- (2009) Kotaro Miyake et al. PANCREAS
- Therapeutic role of sirtuins in neurodegenerative disease
- (2008) Tiago Fleming Outeiro et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer
- (2008) Florian R Fritzsche et al. BMC CANCER
- Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy
- (2008) W Weichert et al. BRITISH JOURNAL OF CANCER
- The Sirtuin family: therapeutic targets to treat diseases of aging
- (2008) Jill C Milne et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- The many roles of histone deacetylases in development and physiology: implications for disease and therapy
- (2008) Michael Haberland et al. NATURE REVIEWS GENETICS
- The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men
- (2008) Xiang-Jiao Yang et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Histone deacetylase 2 expression predicts poorer prognosis in oral cancer patients
- (2008) Hao-Hueng Chang et al. ORAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started